Response to Larry R. White's Letter to the Editor Titled “Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin's Lymphoma: Statistical Errors in Fueger et al. (2009)”

被引：0

作者：

Barbara J. Fueger

Kristen Yeom

Johannes Czernin

James W. Sayre

Michael E. Phelps

Martin S. Allen-Auerbach

机构：

[1] UCLA,Department of Molecular and Medical Pharmacology, David Geffen School of Medicine

[2] UCLA,Department of Radiology, David Geffen School of Medicine

[3] Klinik für Nuklearmedizin,Department of Radiology

[4] AKH Wien,undefined

[5] Stanford University,undefined

来源：

Molecular Imaging and Biology | 2012年 / 14卷

关键词：

Clinical Reality; Bone Marrow Lesion; Expert Reader; Interpretation Criterion; Bone Marrow Uptake;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：399 / 401

页数：2

共 50 条

[41] Prognostic value of semiquantitative analysis of interim 18F-FDG PET/CT in patients with non-Hodgkin's lymphoma.
Henzlova, Lenka
Kapitanova, Zuzana
Koranda, Pavel
Myslivecek, Miroslav
Papajik, Tomas
Buriankova, Eva
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
[42] Diagnostic accuracy of 89Zr-rituximab-PET/CT imaging in patients with relapsed CD20+B-Cell non-Hodgkin's lymphoma: comparison with 18FDG-PET/CT.
Muylle, K.
Vugts, D. J.
Meuleman, N.
Ghanem, G.
Bourgeois, P.
Vanderlinden, B.
Van Dongen, G. A. M. S.
Bron, D.
Flamen, P.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S240 - S240
[43] Diagnostic accuracy of 89Zr-rituximab-PET/CT imaging in patients with relapsed CD20+B-Cell non-Hodgkin's lymphoma: comparison with 18FDG-PET/CT.
Muylle, K.
Vugts, D. J.
Meuleman, N.
Ghanem, G.
Bourgeois, P.
Vanderlinden, B.
Van Dongen, G. A. M. S.
Bron, D.
Flamen, P.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 240 - 240
[44] Utility of PET-CT in staging and early response assessment in adolescent patients with classical Hodgkin's lymphoma (CHL) - A single centre experience
Minson, S.
Aibara, R.
Shaw, P.
Humphries, P.
Bomanji, J.
Kayyani, I.
Hain, S.
Prvulovich, L.
Gaze, M.
Chang, Y.
Shankar, A.
Hough, R.
Daw, S.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 73 - 73
[45] Treatment response evaluation of patients with NHL (Non-Hodgkin's Lymphoma) using texture analysis on baseline 18F-FDG PET/CT study
Saini, Sachin
Pandey, Anil
Arora, Geetanjali
Patel, Chetan
Kumar, Rakesh
JOURNAL OF NUCLEAR MEDICINE, 2023, 64
[46] Deriving global quantitative tumor response parameters from 18F-FDG PET-CT scans in patients with non-Hodgkin's lymphoma
Sampedro, Frederic
Domenech, Anna
Escalera, Sergio
Carrio, Ignasi
NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (04) : 328 - 333
[47] The Role Of 18F-FDG PET/CT In Detection Of Bone Marrow Involvement In Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
Sandoval Moreno, C.
Garcia Alonso, P.
de la Rubia Marcos, M.
Mena Melgar, C.
Tagliatori Nogueira, M.
Herrero Munoz, A.
Paniagua Correa, C.
Castillejos Rodriguez, L.
Ortega Valle, A.
Balsa Breton, M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S560 - S560
[48] Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CT
Papajik, T.
Myslivecek, M.
Skopalova, M.
Malan, A.
Buriankova, E.
Koza, V.
Hnatkova, M.
Trneny, M.
Sedova, Z.
Kubova, Z.
Koranda, P.
Flodr, P.
Jarkovsky, J.
Dusek, L.
Indrak, K.
NEOPLASMA, 2011, 58 (04) : 291 - 297
[49] The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT
Akkas, Burcu E.
Vural, Gulin U.
NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (01) : 50 - 56
[50] Evaluation of bone marrow involvement (BMI) by FDG-PET/CT in patients with newly diagnosed high grade non-Hodgkin's lymphoma
Lee, Yukyung
Hong, Junshik
Hwang, Kyung Hoon
Kim, Seog Gyun
Lee, Haejun
Kim, Jihyun
JOURNAL OF NUCLEAR MEDICINE, 2012, 53

← 1 2 3 4 5 →